Human Papillomavirus

0
Pipeline Programs
3
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

M&
Merck & Co.RAHWAY, NJ
5 programs
Human Papillomavirus (HPV) Infection in Young Men Who Have Sex With MenN/A1 trial
Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)N/A1 trial
Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2)N/A1 trial
KAP/WTP and HPV Prevalence Studies in a Developing World Setting (Bamako, Mali)N/A
Prevalence, Persistence, and Risk Factors for Oral Human Papillomavirus (HPV) Infections in College N/A1 trial
Active Trials
NCT01422356Completed200Est. Sep 2013
NCT01159834Completed1,574Est. Dec 2011
NCT03000933Completed200Est. Dec 2019
+1 more trials
Abbott
AbbottABBOTT PARK, IL
1 program
Alinity m HR HPVN/A1 trial
Active Trials
NCT04746872Completed14,935Est. Nov 2022
Alliance Pharmaceuticals
1 program
KAP/WTP and HPV Prevalence Studies in a Developing World Setting (Bamako, Mali)N/A1 trial
Active Trials
NCT01314404Unknown460Est. Sep 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AbbottAlinity m HR HPV
Merck & Co.Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2)
Merck & Co.Prevalence, Persistence, and Risk Factors for Oral Human Papillomavirus (HPV) Infections in College
Alliance PharmaceuticalsKAP/WTP and HPV Prevalence Studies in a Developing World Setting (Bamako, Mali)
Merck & Co.Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)
Merck & Co.Human Papillomavirus (HPV) Infection in Young Men Who Have Sex With Men

Clinical Trials (6)

Total enrollment: 18,405 patients across 6 trials

NCT04746872AbbottAlinity m HR HPV

Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening

Start: Feb 2021Est. completion: Nov 202214,935 patients
N/ACompleted
NCT03000933Merck & Co.Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2)

Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2)

Start: Jan 2017Est. completion: Dec 2019200 patients
N/ACompleted
NCT01289873Merck & Co.Prevalence, Persistence, and Risk Factors for Oral Human Papillomavirus (HPV) Infections in College

Prevalence, Persistence, and Risk Factors for Oral Human Papillomavirus (HPV) Infections in College Women

Start: May 2011Est. completion: Sep 20121,036 patients
N/ACompleted
NCT01314404Alliance PharmaceuticalsKAP/WTP and HPV Prevalence Studies in a Developing World Setting (Bamako, Mali)

KAP/WTP and HPV Prevalence Studies in a Developing World Setting (Bamako, Mali)

Start: Mar 2011Est. completion: Sep 2012460 patients
N/AUnknown
NCT01159834Merck & Co.Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)

Human Papillomavirus (HPV) Vaccination in Barretos (Pio XII Foundation - Barretos Cancer Hospital)

Start: Sep 2010Est. completion: Dec 20111,574 patients
N/ACompleted
NCT01422356Merck & Co.Human Papillomavirus (HPV) Infection in Young Men Who Have Sex With Men

Human Papillomavirus (HPV) Infection in Young Men Who Have Sex With Men

Start: Sep 2010Est. completion: Sep 2013200 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space